Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management (weight loss and weight maintenance) in adult patients with an initial body mass index (BMI) of 30 kg/m 2 or greater (obesity) or 27 kg/m 2 or greater (excess weight) in the presence of at least one weight related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
The main function of GPX in mammals is to eliminate excessive free radicals in cells, including superoxide anions (O 2- ), H 2 O 2 , and hydroxyl radicals (OH )
March 19, 2026 May 28, 2026 Start your weight loss journey with Yazen today Everything you need to do is to create an account and answer some questions about your health More articles Body mass index (BMI), body measurements and body composition why Yazen uses multiple measures Body mass index (BMI) is a commonly used measure of the relationship between weight and height in weight loss and obesity treatment, but it does not provide the full picture of your health
A brief note on pregnancy and breastfeeding : if you are pregnant, planning a pregnancy, or breastfeeding, you must inform your clinical team immediately